Sveinbjorn Gizurarson

This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: University of Iceland, Hananja Ehf, Capretto Ehf.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sveinbjorn Gizurarson. Retrieved from https://idiyas.com/inventor/sveinbjorn-gizurarson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 81.8

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 85(Granted Patents)

Company Filing History:

4 out of 6

University of Iceland

Hananja Ehf and University of Iceland

patent

7. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12539313 - Microbial removal (2026-02-03),

2. 11337949 - Thermostable formulation of biologically active substances (2022-05-24),

3. 10052333 - Methods and systems for the delivery of a therapeutic agent (2018-08-21),

4. 9968648 - Peptide or protein stabilizing formulation (2018-05-15),

5. 9687495 - Methods and systems for the delivery of a therapeutic agent (2017-06-27),

6. 9289432 - Methods and compositions for the delivery of a therapeutic agent (2016-03-22),

7. 9168284 - Biological activity of placental protein 13 (2015-10-27),

8. 8809322 - Methods and compositions for the delivery of a therapeutic agent (2014-08-19),

9. 8217033 - Methods and compositions for the delivery of a therapeutic agent (2012-07-10),

10. 6855332 - Absorption promoting agent (2005-02-15),

11. 5942237 - Pharmaceutical preparation for topical administration of antigens and/or (1999-08-24),

Title: Sveinbjorn Gizurarson: Revolutionizing Healthcare Through Innovation

Introduction:

Sveinbjorn Gizurarson, a visionary inventor hailing from Reykjavik, Iceland, is at the forefront of technological advancements aimed at enhancing healthcare solutions. With a staggering total of 10 patents to his name, his groundbreaking inventions have significantly impacted the medical field.

Latest Patents:

One of Sveinbjorn's recent patents includes a thermostable formulation of biologically active substances. This innovative formulation allows for the effective administration of antimicrobiologically active monoglyceride to mammals, ensuring the therapeutic effect remains potent within a wide temperature range.

Another noteworthy patent by Sveinbjorn is focused on methods and systems for the delivery of therapeutic agents. This liquid pharmaceutical composition revolutionizes the way therapeutic agents are administered, particularly through intranasal delivery, showcasing his commitment to pushing boundaries in healthcare technology.

Career Highlights:

Throughout his illustrious career, Sveinbjorn has left an indelible mark on the industry through his work with esteemed institutions such as the University of Iceland and Hananja Ehf. His dedication to driving innovation and creating impactful solutions has solidified his status as a pioneering figure in the field of technology and healthcare.

Collaborations:

Sveinbjorn's collaborative spirit has been a driving force behind his success, working closely with talented individuals such as Sigridur Olafsdottir and Jakob Lindal Kristinsson. These fruitful collaborations have led to the development of cutting-edge inventions that have the potential to revolutionize the way healthcare is delivered.

Conclusion:

In conclusion, Sveinbjorn Gizurarson's unwavering passion for innovation and his relentless pursuit of creating a better world through his inventions truly set him apart as a pioneer in the field of technology. His commitment to pushing boundaries and his collaborative efforts with industry experts underscore his significant contributions to the realm of healthcare innovation.

Profile summary based on public USPTO records.